Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that the Office of Hematology and Oncology Products...
November is National Family Caregivers Month—a time to raise awareness for the approximately 3 million people in the U.S....
Lung cancer – one of the most commonly diagnosed cancers in the United States – is an area of...
Earlier this year, the American Association of Cancer Research (AACR) partnered with Novocure, a global oncology company, to launch...
The Centers for Medicare & Medicaid Services offers value-based programs that “reward health care providers with incentive payments for...
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held this year at the Hynes Convention Center in...
As October comes to a close, it’s time for our latest edition of Editors’ Picks. This monthly staple is...
On Wednesday, the U.S. Food and Drug Administration (FDA) expanded the use of the molecularly targeted therapeutic niraparib (Zejula)...